Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Breast Neoplasms 7Carcinoma, Non-Small-Cell Lung 4Triple Negative Breast Neoplasms 3Hodgkin Disease 3Rhabdomyosarcoma, Embryonal 2Rhabdomyosarcoma, Alveolar 2Rhabdomyosarcoma 2Neoplasm Metastasis 2Uterine Cervical Neoplasms 1Sarcoma 1Recurrence 1Neoplasms 1Lung Neoplasms 1Lung Diseases, Interstitial 1HR+HER2- Breast Cancer 1Desmoplastic Small Round Cell Tumor 1Adenocarcinoma 1

Interventions

Specimen Handling 51Carboplatin 49pembrolizumab 45Magnetic Resonance Spectroscopy 43Pemetrexed 39Cisplatin 34Paclitaxel 24durvalumab 23osimertinib 20Nivolumab 19Gemcitabine 19Radiosurgery 17Docetaxel 17atezolizumab 14Taxes 12Radiotherapy 12Immunoglobulin G 12Disulfides 12130-nm albumin-bound paclitaxel 12Etoposide 11Educational Status 11Biopsy 11Radiation 10Drug Therapy 10Blood Specimen Collection 10Platinum 9Early Intervention, Educational 9Cetuximab 9Methods 8Bevacizumab 8

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Lung Neoplasms × Vinorelbine × 90 days × Clear all
NCT06632327 2026-06-02

Comparing Impact of Treatment Before or After Surgery in Patients With Stage II-IIIB Resectable Non-small Cell Lung Cancer

Alliance for Clinical Trials in Oncology

Phase 3 Recruiting
1,100 enrolled
Thoracic

Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡